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Lead is a toxic metal that induces a wide range of behavioral, biochemical and physiological effects in
humans. Oxidative damage has been proposed as a possible mechanism involved in lead toxicity. The
current study was carried out to evaluate the antioxidant activities of Spirulina supplement against lead
acetate -induced hepatic injury in rats. Five groups of rats were used in this study, Control, Lead acetate
(100 mg/kg), Lead acetate (100 mg/kg) þ 0.5 g/kg Spirulina, Lead acetate (100 mg/kg) þ 1 g/kg Spirulina
and Lead acetate þ 25 mg/100 g Vitamin C (reference drug). All experimental groups received the oral
treatment by stomach tube once daily for 4 weeks. Lead intoxication resulted in a signiﬁcant increase in
serum alanine transaminae (ALT), aspartate transaminae (AST) activities, liver homogenate tumor ne-
crosis factor-a (TNF-a), caspase-3, malondialdehyde (MDA), nitric oxide (NO) levels and a signiﬁcant
decline of total serum protein, liver homogenate reduced glutathione (GSH) level and superoxide dis-
mutase (SOD) activity. Both doses of Spirulina supplement as well as Vitamin C succeeded to improve the
biochemical parameters of serum and liver and prevented the lead acetate-induced signiﬁcant changes
on plasma and antioxidant status of the liver. Both doses of Spirulina supplement had the same anti-
apoptotic activity and high dose exhibited more antioxidant activity than that of low dose. In conclu-
sion, the results of the present work revealed that Spirulina supplement had protective, antioxidant and
anti-apoptotic effects on lead acetate-induced hepatic damage.
Copyright © 2016, Center for Food and Biomolecules, National Taiwan University. Production and hosting
by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Lead (Pb) is a toxic metal that induces a wide range of behav-
ioral, biochemical and physiological effects in humans. Even though
blood lead levels continue to decline over the past two decades,
speciﬁc populations like infants, young children and working class
are still at a higher risk.1 Childhood lead exposure is estimated to
contribute to about 600 000 new cases of children developing in-
tellectual disabilities every year. Lead exposure is estimated to ac-
count for 143 000 deaths per year with the highest burden in
developing regions. About one half of the burden of disease from
lead occurs in the WHO South-East Asia Region, with about one-
ﬁfth each in the WHO Western Paciﬁc and Eastern Mediterranean
Regions.2 As lead exposure tends to be sub acute, produces onlyfor Food and Biomolecules,
molecules, National Taiwan Unive
ons.org/licenses/by-nc-nd/4.0/).subtle clinical symptoms. Chronic exposure cases are more com-
mon than acute toxicity. Lead via gastro intestinal absorption is ﬁrst
taken up by the red blood cells and is distributed to all vascular
organs.3 Pathogenesis of lead poisoning is mainly attributed to
lead-induced oxidative stress. Chronic lead exposure is known to
disrupt the pro oxidant/antioxidant balance existing within the
mammalian cells.4,5 Lead is reported to cause oxidative stress by
generating the release of reactive oxygen species (ROS) such as
superoxide radicals, hydrogen peroxide and hydroxyl radicals and
lipid peroxides. There has been increased interest among phyto-
therapy researchers to use medicinal plants with antioxidant
activity for protection against heavy metal toxicity.6e8
Pharmaceutical drugs that depend on compounds such as
colchicine and interferons are currently available for the treatment
of liver cirrhosis but with either unreliable efﬁcacies or high situ-
ations of side effects.9
A number of natural compounds produced fromvegetation offer
alternative healthcare options that are more effective and safe.10
Ingredients from recently found or already known plant varietiesrsity. Production and hosting by Elsevier Taiwan LLC. This is an open access article
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spective tasks and efﬁciency of plant extracts in liver diseases are
yet to be analyzed. Spirulina Slimming Capsule, the product choo-
ses the natural herbal product combining Spirulina platensis and
Aloe extract.
Spirulina is a great source of natural protein (about 60%
digestible proteins). It is a low fat, low calorie, cholesterol free
source of protein with all amino acids, phyto-nutrients, antioxi-
dants, carbohydrate, muco-polysacchrides, vitamins and trace
minerals, an exclusive ingredient, prevents the digestion of dietary
fat, hence reducing its absorption by the body. After sometime of
consumption, body parts prone to fat accumulation (belly, arms,
thighs and buttoks) could see dramatic beneﬁts. Spirulina soft
capsule promote gastrointestinal motility, remove intestinal toxins,
improve constipation. Spirulina Slimming. It can reduce the ab-
sorption of lipophilic analogs by intestinal tract, control the
ingestion of heat quantity, avoid the storage of fat, plug up the
source of fat and burn the quondam fat by the way of heat pro-
duction. It accelerate the metabolic rate of fat, which change the fat
into sugar and protein, to protect the nutrition that people need
and keep slimming. In addition, it has the function of hairdressing.
Many people ﬁnd it effective as a natural appetite suppressant. It is
also known to assist blood circulation. The present study was
planned to investigate the antioxidant, heptoprotective and
apoptotic effects of Spirulina supplement against lead-induced
hepatic injury and apoptotic changes in rats.
2. Materials & methods
Spirulina Slimming, Fat Burner Capsules 350 mg (China
go2slimming LLC NO.315 Kunming Luosiwan Commercial Center
Kunming, Yunnan, China 650214) was purchased from private
Pharmacy, Cairo, Egypt.
2.1. Experimental design
Thirty male Wistar albino rats weighing (140e160) g were used
for this study. The animals were housed in a temperature
(25 ± 1 C), humidity controlled room and a 12-h light-dark cycle.
Rats were allowed free access to tap water and standard pellet diet.
The institutional Animal Ethics Committee approved all experi-
mental protocols. The animals were classiﬁed into 5 groups, each of
6 as follows:
Control group (C): Rats received distilled water.
Lead acetate-treated group (LA): Rats were orally administered
lead acetate at a dose of 100 mg lead acetate/kg body weight, by
stomach tube once daily for 4 weeks.
Lead acetate and 0.5 g/kg Spirulina treated group
(LA þ 0.5 g/kg Spirulina): Rats were orally administered lead
acetate at a dose of 100 mg lead acetate/kg body weight and
0.5 g Spirulina/kg body weight by stomach tube once daily for 4
weeks.
Lead acetate and 1 g/kg Spirulina treated group (LA þ 1 g/kg
Spirulina): Rats were orally administered lead acetate at a dose
of 100 mg lead acetate/kg body weight and 1 g Spirulina/kg
body weight by stomach tube once daily for 4 weeks.
Lead acetate and 25 mg/100 g Vitamin C(reference drug)
treated group (LA þ 25 mg/100 g Vitamin C): Rats were orally
administered 100 mg lead acetate/kg body weight and 25 mg
Vitamin C/100 gm body weight by stomach tube once daily for 4
weeks.
At the end of experiment, fasting blood samples were with-
drawn from the retro-orbital vein of each animal using a glasscapillary tube after fasting period of 12 h. The blood samples
allowed to coagulate and then centrifuged at 3000 rpm for 20 min.
The separated sera were used for the estimation of serum activities
of ALT and AST by using commercial kits (Quimica Clinica Aplicada,
Spain). Total serum protein was evaluated using kits from Bio-
diagnostic, Egypt.2.2. Preparation of liver homogenate
A portion of liver was excised, accurately weighed and homog-
enized in ice-saline to prepare a 10% (w/v) tissue homogenate. The
homogenate was used for the determination of GSH level, SOD
activity, end product of lipid perioxidation, MDA and NO levels.
The protein content of liver homogenates was evaluated by the
method of Lowry et al12 and using bovine serum albumin as a
standard. GSH level in liver tissue was measured by the method of
Ellman using 5, 50-dithiobis-(2-nitrobenzoate) at 412 nm.13
SOD activity in liver tissue was determined by the method of
Marklund and Marklund14 pyrogallol (24 mmol/L) was prepared in
10 mM HC1 and kept at 4 C Before use. Stock catalase solution
(30 mmol/L) was prepared in phosphate buffer (pH 9, 0.1 M), 100 ml
of the supernatant was added to Tris HC1 buffer (pH 7.8, 0.1 M)
containing 25 ml pyrogallol and 10 ml catalase. The ﬁnal volume was
adjusted to 3 ml using the same buffer solution. Changes in the
absorbance at 420 nm were recorded at 1 min interval for 3 min.
Data were expressed as U/mg protein.
In liver homogenate, MDA, a stable product of lipid peroxi-
dation was estimated by method of Ohkawa.15 In brief, 0.5 ml of
homogenate was mixed with 2.5 ml of 20% trichloroacetic acid
and centrifuged at 3000 rpm for 10 min. The supernatant was
decanted and the precipitate was washed once with 0.05 M
sulphuric acid and then 3 ml of 0.2 g/dl thiobarbituric acid re-
agent was added to the precipitate. The mixture was heated in a
boiling water bath for 30 min. After cooling in cold water, the
resulting chromogen was extracted with 4 ml of n-butyl alcohol.
The organic phase was separated by centrifugation at 3000 rpm
for 10 min and absorbance was recorded at wavelength of
530 nm.
NO level in liver tissues was measured by using the commercial
kits supplied by Biodiagnostic, Egypt. The assay is based on the
diazotization of sulfanilic acid with nitric oxide at acidic pH and
subsequent coupling with N-(1-naphthyl)-ethylenediamine to
yield an intensely pink colored product that was measured
spectrophotometrically at 540 nm. Sodium nitrite was used as
standard.2.3. Estimation of TNF-a and caspase-3 levels
A portion of the liver was weighed (50 mg) and homogenized in
0.8 ml lysis buffer, pH 7.4. The lysate was centrifuged at 10 000 g for
15 min at 4 C, and the supernatant was taken for estimation of the
TNF-a and caspase-3 levels by a sandwich enzyme immunoassay
kit (Cloud Clone Corp.) for in vitro quantitative measurement of
TNF-a and caspase-3 level in rat tissue homogenates.2.4. Statistical analysis
Results were shown as mean ± S.E. for each group. Statistical
analysis was performed using SPSS 9.0 for Windows (Chicago, IL,
USA). For multiple comparisons, one-way analysis of variance
(ANOVA) was used. In cases where ANOVA showed signiﬁcant
differences, Tukey test was performed. P < 0.05 was considered to
be statistically signiﬁcant.
Table 1
Serum total protein, ALT and AST activities in control (C), lead acetate (LA), LA þ 0.5 g Spirulina/kg, LA þ 1 g Spirulina/kg and 25 mg Vitamin C/100 g bwt, treated groups.
Control Lead acetate Lead acetate þ 0.5 g
Spirulina/kg bwt
Lead acetate þ 1 g
Spirulina/kg bwt
Lead acetate þ 25 mg
vitamin C/kg bwt
Total protein (g/dl) 7.47 ± 0.3 6 ± 0.17a 6.89 ± 0.13b 7 ± 0.16b 7.32 ± 0.31b
ALT (U/L) 26.7 ± 0.6 95.8 ± 3.3a 47.5 ± 2.1a,b,c,d 27.6 ± 0.6b 28.3 ± 0.46b
AST (U/L) 34.8 ± 0.6 81.5 ± 2.6a 65 ± 1.43a,b,c,d 35.4 ± 0.88b 36.9 ± 0.9b
Results are expressed as mean ± S.E.
P < 0.05 was considered to be statistically signiﬁcant.
a Signiﬁcantly different from control group.
b Signiﬁcantly different from lead acetate treated group.
c Signiﬁcantly different from lead acetate (LA) þ 1 g Spirulina/kg bwt, treated group.
d Signiﬁcantly different from lead acetate (LA) þ and 25 mg Vitamin C/100 g bwt, treated group.
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3.1. Body weight
In the lead treated animals there was a signiﬁcant reduction in
the body weight (140 ± 2.9) as compared to their corresponding
control animals after 4 weeks (175 ± 5), P < 0.05. While protection
with 0.5 g, 1 g Spirulina as well Vitamin C showed signiﬁcant in-
crease in their body weight (160.6 ± 6), (165 ± 7) and (164 ± 5),
respectively, when compared with that of lead acetate treated
group, P < 0.05.3.2. Effect of Spirulina supplement on serum ALT, AST activities and
total protein
Lead toxicity caused a signiﬁcant increase in serum ALT, AST
activities and a signiﬁcant decrease in total serum protein as0
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Fig. 1. Effect of Spirulina supplement on liver homogenate GSH (A), SOD(B), MDA (C) and NO
LA þ 25 mg Vitamin C/100 g bwt, treated groups. Data represent the means ± S.E.M (n ¼ 6). a
group. c: Signiﬁcantly different from lead acetate (LA) þ 1 g Spirulina/kg bw, treated group.
group.compared to their corresponding controls, P < 0.05. Administration
of Spirulina supplement with two doses as well as Vitamin C to
lead-intoxicated rats revealed a signiﬁcant decrease in serum ALT,
AST activities and a signiﬁcant increase in total serum protein as
compared to lead treated animals, P < 0.05, (Table 1).3.3. Effect of Spirulina supplement on GSH level and SOD activity in
liver homogenate
Lead toxicity caused a signiﬁcant decrease in GSH level and SOD
activity in liver homogenate when compared to their perspective
controls, P < 0.05. Administration of Spirulina supplement with
two doses as well as Vitamin C to lead-intoxicated rats revealed a
signiﬁcant increase in GSH level and SOD activity as compared to
lead treated animals, but the higher dose showed a more signiﬁ-
cant antioxidant effect than that of lower dose, P < 0.05, Fig. 1(A)
and (B).0
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(D) in control (C), lead acetate (LA), LA þ 0.5 g Spirulina/kg, LA þ 1 g Spirulina/kg and,
: Signiﬁcantly different from control. b: Signiﬁcantly different from lead acetate treated
d: Signiﬁcantly different from lead acetate (LA) þ 25 mg Vitamin C/100 g bwt, treated
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homogenate
Lead toxicity caused a signiﬁcant increase of MDA and NO levels
in liver homogenate as compared to their corresponding controls,
P < 0.05. Treatment of Spirulina supplement with two doses as well
as Vitamin C to lead-intoxicated rats showed a signiﬁcant decrease
in MDA and NO levels as compared to lead treated animals, but the
high dose exhibited lower signiﬁcant values of MDA and NO than
that of lower dose, P < 0.05, Fig. 1(C) and (D).
3.5. Effect of Spirulina supplement on TNF-a and caspase-3 levels in
liver homogenate
Lead toxicity caused a signiﬁcant increase of TNF-a and caspase-
3 levels in liver homogenate when compared to their correspond-
ing controls, P < 0.05. Treatment of Spirulina supplement with two
doses as well as Vitamin C to lead-intoxicated rats revealed a sig-
niﬁcant decrease in TNF-a and caspase-3 levels as compared to lead
treated animals, P < 0.05, Fig. 2(A) and (B).
4. Discussion
The liver is considered one of the target organs affected by lead
toxicity owing to its storage in the liver after lead exposure. Also,0
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Fig. 2. Effect of Spirulina supplement on liver homogenate TNF- a (A) and Caspase-3
(B) level in control (C), lead acetate (LA), LA þ 0.5 g Spirulina/kg, LA þ 1 g Spirulina/
kg and, LA þ 25 mg Vitamin C/100 g bwt, treated groups. Data represent the
mean ± S.E.M (n ¼ 6). a: Signiﬁcantly different from control. b: Signiﬁcantly different
from lead acetate treated group.the liver being one of the major organs involved in the storage,
biotransformation and detoxiﬁcation of toxic substances, is of in-
terest in heavy metal poisoning.16 The present study was planned
to investigate the antioxidant, anti-apoptotic and heptoprotective
effects of Spirulina supplement against lead-induced hepatic injury
in rats.
The activities of ALTand ASTare indicators of hepatotoxicity.17 In
the present study, there was a signiﬁcant increase of ALT and AST
activities in lead treated group as compared to the control group.
These results showed that the exposure to lead affects hepatic
tissue, which is consistent with other reports.18
Lead is a heavy metal that produces oxidative damage in the
liver by enhancing lipid peroxidation.19 Lead toxicity leads to free
radical damage by two separate, although related, pathways: (1)
the generation of reactive oxygen species (ROS), including hy-
droperoxides, singlet oxygen, and hydrogen peroxides, evaluated
by MDA levels as the ﬁnal products of lipid peroxidation, and (2)
the direct depletion of antioxidant reserves.20 In the present
study, there was signiﬁcant increase of MDA levels and a signif-
icant decrease of GSH levels in lead-intoxicated rats. Our results
are in agreement with other previous studies.21,22 Also, in the
present work, there was a signiﬁcant decrease in SOD activity in
lead-intoxicated rats. These results were in agreement with that
of Ponce-Canchihuaman et al.23 The presence of increased MDA
level observed in the current study was also due to decreased
SOD activity, an indicator of oxidative stress. The possible
explanation could be related to the proposed role of GSH in the
active excretion of lead through bile by binding to the thiol group
of GSH and then being excreted. A decrease in GSH levels could
lead to oxidative stress and a consequent increase in MDA.6
Among therapeutics for liver diseases, protective drugs such as
antioxidants have attracted more and more attention and proton
radical-scavenging action is well known as an important mech-
anism of antioxidation. In our work, the treatment of lead-
intoxicated rats with Spirulina supplement revealed a signiﬁ-
cant increase in GSH level, SOD activity, decrease in MDA and NO
levels as compared to lead-intoxicated rats indicating its anti-
oxidant activity.
In order to evaluate the hepatic inﬂammation and apoptosis,
TNF- a and caspase-3 were measured. Lead, in the present study,
caused marked increase in hepatic TNF-a level, which were
consistent with previous report.24 On the other hand, increased
oxidative stress caused disturbances in mitochondrial membrane
permeability, causing leakage of free radicals and cytochrome-c
from the mitochondria to the cytosol. Once cytochrome-c is
released into the cytosol, it binds to another protein, Apaf-1, and
promotes activation of the caspase cascade, leading to cell death.25
In the present study, Spirulina treatment signiﬁcantly reduced the
elevated levels of hepatic TNF-a and caspase-3 observed in the lead
treated group an effect that might be attributed to reduction in
oxidative stress. Treatment of lead-intoxicated animals with two
doses of Spirulina supplement (0.5 and 1 g/Kg body weight)
showed anti-inﬂammatory, anti-apoptotic and anti-oxidant activ-
ities, while the antioxidant activity was more pronounced in the
dose of 1 g/Kg body weight.
One of the components of Spirulina supplement is Spirulina
platensis, is blue - green algae due to the presence of both chloro-
phyll (green) and phycocyanin (blue) pigments in its cellular
structure. Chlorophyll (green) helps cleanse the body of toxins,
phycocyanin (blue) supports protein absorption and healthy im-
mune function and beta carotene (orange) encourages antioxidant
activity. Spirulina contains all eight essential amino acids, making it
a complete protein, plus B-complex vitamins, beta carotene,
vitamin E, carotenoids, manganese, zinc, copper, iron, gamma
linoleic acid (GLA) and calcium.26
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investigated the protective effects of the biomass of Spirulina pla-
tensiswith low amounts of phenolics (SP1) and with high amounts
of phenolics (SP2) against CCl4-induced acute hepatotoxicity in rats.
The author concluded that showed that SP2 was more potent than
SP1 in protecting the liver from toxic injury of CCl4 and preserving
the hepatocyte ultrastructure and suggested that the probable
superiority of SP2 in hepatoprotective activity in rats might be due
to the following effects: stabilizing the hepatocyte membrane by
preventing lipid peroxidation, ameliorating the activities of the
antioxidant enzymes, inhibition of the inﬂammation and the radical
scavenging activity. These effects might be attributed to the
increased amounts of phycocyanine and phenolic compounds and
the antioxidant capacity as conﬁrmed by three different antioxidant
activity tests. Probably, SP2 restored the liver injuries by scavenging
the free radicals generated by CCl4 and preventing infIammation
more effectively. The increased phycocyanine content of SP2 may
also be partly involved in the inﬂammatory processes. It has been
recently reported that phycocyanine could block inﬂammatory
inﬁltration through its anti-inﬂammatory activities.27
Also, in our study, Spirulina succeeded to induce an improve-
ment in body weight and the biochemical parameters. Several re-
ports have indicated that Spirulina has antioxidant effects28e30 due
to its higher content of some macro- and micronutrients including
high quality protein, iron, gamma-linolenic fatty acid, carotenoids,
vitamins B1 and B231 b-carotene, a-tocopherol and phycocyanin.32
The phycocyanin has been considered the predominant compound
in the antioxidant activity of the Spirulina.33,34
The other component of Spirulina supplement is Aloe extract. In
another work by Chandan et al35 the author studied hep-
atoprotective potential of Aloe barbadensis against carbon tetra-
chloride induced hepatotoxicity. The author reported that the
possible mechanism of hepatoprotective action of Aloe barbadensis
extract may be due to its antioxidant activity as indicated by pro-
tection against increased lipid peroxidation and maintained
glutathione contents.5. Conclusion
This study has demonstrated that exposure to lead could have
generated oxidative stress which resulted in lipid peroxidation in
the liver associated with the reduction in the antioxidant status.
Spirulina supplement co-treatment resulted in the prevention of
the lead induced damages.
The protective effects of Spirulina supplementmay be due to the
radical scavenging activity of its components. Consequently, higher
dose of Spirulina supplement could be useful in the preventive
treatment of lead toxicity. Further extensive studies are needed to
use Spirulina as a economic therapy in lead poisoning and to assess
the safety of Spirulina in children.References
1. Godwin HA. The biological chemistry of lead. Curr Opin Chem Biol. 2001;5:
223e227.
2. WHO Lead poisoning and health, Fact sheet N379 Reviewed October 2014.
3. Rahman S, Sultana S. Chemopreventive activity of glycyrrhizin on lead acetate
mediated hepatic oxidative stress and its hyperproliferative activity inWistar
rats. Chem Biol Interact. 2006;160:61e69.
4. Bolin CM, Basha R, Cox D, et al. Exposure to lead and the developmental origin
of oxidative DNA damage in the aging brain. FASEB J. 2006;20:788e790.
5. Hsu CP, Guo LY. Antioxidant nutrients and lead toxicity. Toxicol. 2002;180:
33e44.6. Senapati SK, Dey S, Dwivedi SK, Swarup D. Effect of garlic (Allium sativum L.)
extract on tissue lead levels in rats. J Ethnopharmacol. 2001;76:229e232.
7. Singh MK, Dwivedi S, Yadav SS, Sharma P, Khattri S. Arsenic induced hepatic
toxicity and its attenuation by fruit extract of Emblica ofﬁcinalis (Amla) in mice.
Indian J Clin Biochem. 2014;29:29e37.
8. Hsu PC, Liu MY, Hsu CC, Chen LY, Leon GY. Lead exposure causes generation of
reactive oxygen species and functional impairment in rat sperm. Toxicol.
1997;122:133e143.
9. Xu Y, Li G, Han C, Sun L, Zhao R, Cui S. Protective effect of Hippophae rhamnoides
L. juice on lead induced neurotoxicity in mice. Biol Pharm Bull. 2005;28:
490e494.
10. Raison CL, Demetrashvili M, Capuron L, Miller AH. Neuropsychiatric adverse
effects of interferon-a: recognition and management. CNS Drugs. 2005;19:
105e123.
11. Yang H, Sung SH, Kim YC. Two new hepatoprotective stilbene glycosides from
acer mono leaves. J Nat Prod. 2005;68:101e103.
12. Wang N, Li P, Wang Y, et al. Hepatoprotective effect of Hypericum japonicum
extract and its fractions. J Ethnopharmacol. 2008;116:1e6.
13. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. J Biol Chem. 1951;193:265 (The
original method).
14. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959;74:214e216.
15. Marklund SL, Marklund G. Involvement of the superoxide anion radical in the
autooxidation of pyrogallol and convenient assay for superoxide dismutase.
Eur J Biopchem. 1974;47:469e474.
16. Ohkawa H, Ohishi N, Yagi K. Assay of lipid peroxide in animal tissue by thio-
barbituric acid reaction. Ann Biochem. 1979;95:351e358.
17. Herman DS, Geraldine M, T V. Inﬂuence of minerals on lead-induced alterations
in liver function in rats exposed to long-term lead exposure. J Hazard Mater.
2009;166:1410e1414.
18. Yang RZ, Park S, Reagan WJ, et al. Alanine aminotransferase isoenzymes: mo-
lecular cloning and quantitative analysis of tissue expression in rats and serum
elevation in liver toxicity. Hepatology. 2009;49:598e607.
19. Can S, Bagci C, Ozaslan M, et al. Occupational lead exposure effect on liver
functions and biochemical parameters. Acta Physiol Hung. 2008;95:395e403.
20. El-Nekeety AA, El-Kady AA, Soliman MS, Hassan NS, Abdel-Wahhab MA. Pro-
tective effect of Aquilegia vulgaris (L.) against lead acetate-induced oxidative
stress in rats. Food Chem Toxicol. 2009;47:2209e2215.
21. Newairy AS, Abdou HM. Protective role of ﬂax lignans against lead acetate
induced oxidative damage and hyperlipidemia in rats. Food Chem Toxicol.
2009;47:813e818.
22. Reglero MM, Taggart MA, Monsalve-Gonzalez L, Mateo R. Heavy metal expo-
sure in large game from a lead mining area: effects on oxidative stress and fatty
acid composition in liver. Environ Pollut. 2009;157:1388e1395.
23. Upasani CD, Balaraman R. Protective effect of Spirulina on lead induced dele-
terious changes in the lipid peroxidation and endogenous antioxidants in rats.
Phytother Res. 2003;17:330e334.
24. Ponce-Canchihuaman JC, Perez-Mendez O, Hernandez-Mu~noz R, Torres-
Duran PV, Juarez-Oropeza MA. Protective effects of Spirulina maxima on
hyperlipidemia and oxidative-stress induced by lead acetate in the liver and
kidney. Lipids Health Dis. 2010;9:35e41.
25. Liu MY, Cheng YJ, Chen CK, Yang BC. Co exposure of lead- and
lipopolysaccharide-induced liver injury in rats: involvement of nitric oxide-
initiated oxidative stress and TNF-alpha. Shock. 2005;23:360e364.
26. Holly TA, Drincic A, Byun Y, et al. Caspase inhibition reduces myocyte cell death
induced by myocardial ischemia and reperfusion in vivo. J Mol Cell Cardiol.
1999;31:1709e1715.
27. Karadeniz A, Yildirim A, Simsek N, Kalkan Y, Celebi F. Spirulina platensis pro-
tects against gentamicin-induced nephrotoxicity in rats. Phytother Res. 2008;
22:1506e1510.
28. Kepekçi RA, Polat S, Çelik A, Bayat N, Saygideger SD. Protective effect of Spir-
ulina platensis enriched in phenolic compounds against hepatotoxicity induced
by CCl4. Food Chem. 2013;141:1972e1979.
29. Park HJ, Lee YJ, Ryu HK, Kim MH, Chung HW, Kim WY. A randomized double-
blind, placebo-controlled study to establish the effects of spirulina in elderly
Koreans. Ann Nutr Metab. 2008;52:322e328.
30. Ba~nos G, Perez-Torres I, El Haﬁdi M. Medicinal agents in the metabolic syn-
drome. Cardiovasc Hematol Agents Med Chem. 2008;6:237e252.
31. Thaakur SR, Jyothi B. Effect of Spirulina maxima on the haloperidol induced
tardive dyskinesia and oxidative stress in rats. J Neural Transm. 2007;114:
1217e1225.
32. Mazo VK, Gmoshinskiĭ IV, Zilova IS. Microalgae Spirulina in human nutrition.
Vopr Pitan. 2004;73:45e53.
33. Khan Z, Bhadouria P, Bisen PS. Nutritional and therapeutic potential of Spir-
ulina. Curr Phram Biotechnol. 2005;6:373e379.
34. Wang L, Pan B, Sheng J, Xu J, Hu Q. Antioxidant activity of Spirulina platensis
extracts by supercritical carbon dioxide extraction. Food Chem. 2007;105:
36e41.
35. Chandan BK, Saxena AK, Shukla S, et al. Hepatoprotective potential of Aloe
barbadensis Mill. against carbon tetrachloride induced hepatotoxicity.
J Ethnopharmacol. 2007;111:560e566.
